Tilray Expands Medical Cannabis Portfolio in Germany

Core Insights - Tilray Medical is expanding its medical cannabis extract portfolio in Germany, introducing new product sizes and formulations to meet patient and healthcare provider needs [1][3] - The new offerings include a high-potency 1:1 medical cannabis extract (Tilray THC50 CBD50, 25ml) and a trial size version of its top-selling extract (Tilray THC10 CBD10, 10ml) [1][2] - The company emphasizes its commitment to innovation and patient care, which has established it as a leading provider of medical cannabis extracts in Germany [3] Product Offerings - The new Tilray THC50 CBD50 (25ml) is designed for patients requiring higher cannabinoid content, maintaining a balanced THC:CBD ratio [1] - The Tilray THC10 CBD10 (10ml) is a smaller format aimed at facilitating initial dosing and treatment exploration for patients and physicians [2] Company Background - Tilray Medical is part of Tilray Brands, Inc., which operates globally and is dedicated to providing safe and reliable access to medical cannabis [4] - The company has established itself as a leading supplier of medical cannabis, with a portfolio that includes various brands and products tailored to patient needs [4]